Patent details

EP3957752 Title: TREATMENT AND INHIBITION OF INFLAMMATORY LUNG DISEASES IN PATIENTS HAVING RISK ALLELES IN THE GENES ENCODING IL33 AND IL1RL1

Basic Information

Publication number:
EP3957752
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP211623160
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TREATMENT AND INHIBITION OF INFLAMMATORY LUNG DISEASES IN PATIENTS HAVING RISK ALLELES IN THE GENES ENCODING IL33 AND IL1RL1
French Title of Invention:
TRAITEMENT ET INHIBITION DES MALADIES PULMONAIRES INFLAMMATOIRES CHEZ DES PATIENTS POSSÉDANT DES ALLÈLES DE RISQUE DANS LES GÈNES CODANT POUR L'IL33 ET IL1RL1
German Title of Invention:
BEHANDLUNG UND HEMMUNG VON ENTZÜNDLICHEN LUNGENERKRANKUNGEN BEI PATIENTEN MIT RISIKOALLELEN IN DEN FÜR IL33 UND IL1RL1 CODIERENDEN GENEN
SPC Number:

Dates

Filing date:
20/03/2018
Grant date:
20/08/2025
EP Publication Date:
23/02/2022
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
20/08/2025
EP B1 Publication Date:
20/08/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
20/03/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/08/2025
 
 

Name:
Regeneron Pharmaceuticals, Inc.
Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591, United States (US)

Inventor

1

Name:
BRUSE, Shannon
Address:
United States (US)

2

Name:
DEWEY, Frederick
Address:
United States (US)

3

Name:
MCCARTHY, Shane
Address:
United States (US)

4

Name:
GOTTESMAN, Omri
Address:
United States (US)

5

Name:
BARAS, Aris
Address:
United States (US)

Priority

Priority Number:
201762485077 P
Priority Date:
13/04/2017
Priority Country:
United States (US)

Classification

IPC classification:
C12Q 1/6883;

Publication

European Patent Bulletin

Issue number:
202534
Publication date:
20/08/2025
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/03/2026
Annual Fee Number:
9
Annual Fee Amount:
115 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages